Breaking News Instant updates and real-time market news.

CVS

CVS Health

$65.97 /

+1.31 (+2.03%)

08:02
05/28/20
05/28
08:02
05/28/20
08:02

CVS Health establishes 1,000 COVID-19 test sites across the country

Delivering on a commitment the company made in April, CVS Health will open additional COVID-19 test sites at select CVS Pharmacy drive-thru locations on Friday, May 29 to establish a total of 1,000 sites across more than 30 states and Washington, DC.

  • 14

    Sep

CVS CVS Health
$65.97 /

+1.31 (+2.03%)

05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital

TODAY'S FREE FLY STORIES

Options
SunPower call volume above normal and directionally bullish » 12:05
07/14/20
07/14
12:05
07/14/20
12:05
SPWR

SunPower

$9.39 /

+0.43 (+4.80%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$9.39 /

+0.43 (+4.80%)

SPWR SunPower
$9.39 /

+0.43 (+4.80%)

05:27 Today Spin-Off Research
SunPower downgraded to Sell from Hold at Spin-Off Research
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
05/28/20 JPMorgan
SunPower price target raised to $10 from $9 at JPMorgan
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
SPWR SunPower
$9.39 /

+0.43 (+4.80%)

  • 21
    Nov
SPWR SunPower
$9.39 /

+0.43 (+4.80%)

SPWR SunPower
$9.39 /

+0.43 (+4.80%)

Conference/Events
Sanderson Farms participates in a conference call hosted by Stephens » 12:04
07/14/20
07/14
12:04
07/14/20
12:04
SAFM

Sanderson Farms

$116.68 /

+1.13 (+0.98%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAFM Sanderson Farms
$116.68 /

+1.13 (+0.98%)

SAFM Sanderson Farms
$116.68 /

+1.13 (+0.98%)

06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/03/20 Stephens
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers
05/11/20 Stephens
Sanderson Farms price target raised to $150 from $110 at Stephens
04/03/20 Credit Suisse
Sanderson Farms price target lowered to $135 from $160 at Credit Suisse
SAFM Sanderson Farms
$116.68 /

+1.13 (+0.98%)

SAFM Sanderson Farms
$116.68 /

+1.13 (+0.98%)

SAFM Sanderson Farms
$116.68 /

+1.13 (+0.98%)

Recommendations
Capgemini price target raised to EUR 150 from EUR 130 at Credit Suisse » 12:03
07/14/20
07/14
12:03
07/14/20
12:03
CGEMY

Capgemini

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGEMY Capgemini
$0.00 /

+ (+0.00%)

07/10/20 Barclays
Capgemini price target raised to EUR 102 from EUR 79 at Barclays
06/29/20 HSBC
Capgemini downgraded to Hold from Buy at HSBC
06/23/20 Berenberg
Capgemini price target raised to EUR 118 from EUR 111 at Berenberg
06/23/20 Citi
Capgemini resumed with a Buy at Citi
Conference/Events
Relmada Therapeutics participates in a conference call hosted by SunTrust » 12:02
07/14/20
07/14
12:02
07/14/20
12:02
RLMD

Relmada Therapeutics

$40.40 /

-0.15 (-0.37%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLMD Relmada Therapeutics
$40.40 /

-0.15 (-0.37%)

RLMD Relmada Therapeutics
$40.40 /

-0.15 (-0.37%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
05/27/20 Goldman Sachs
Goldman says Relmada clearance for Phase 3 supports REL-1017 safety, efficacy
05/04/20 SunTrust
Relmada Therapeutics initiated with a Buy at SunTrust
05/04/20
Fly Intel: Top five analyst initiations
  • 04
    Dec
Recommendations
BP price target lowered to 350 GBp from 360 GBp at Credit Suisse » 12:02
07/14/20
07/14
12:02
07/14/20
12:02
BP

BP

$23.13 /

+0.665 (+2.96%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$23.13 /

+0.665 (+2.96%)

BP BP
$23.13 /

+0.665 (+2.96%)

07/01/20 Barclays
BP price target raised to 400 GBp from 380 GBp at Barclays
07/01/20 JPMorgan
BP price target lowered to 400 GBp from 425 GBp at JPMorgan
06/17/20 UBS
BP price target lowered to 370 GBp from 400 GBp at UBS
06/15/20 UBS
BP price target lowered to 400 GBp from 410 GBp at UBS
BP BP
$23.13 /

+0.665 (+2.96%)

BP BP
$23.13 /

+0.665 (+2.96%)

BP BP
$23.13 /

+0.665 (+2.96%)

BP BP
$23.13 /

+0.665 (+2.96%)

Hot Stocks
Wells Fargo sees charge-offs moving higher through end of year  12:01
07/14/20
07/14
12:01
07/14/20
12:01
WFC

Wells Fargo

$24.14 /

-1.29 (-5.07%)

 
ShowHide Related Items >><<
WFC Wells Fargo
$24.14 /

-1.29 (-5.07%)

WFC Wells Fargo
$24.14 /

-1.29 (-5.07%)

07/10/20 Baird
Wells Fargo upgraded to Outperform from Neutral at Baird
07/09/20 Wolfe Research
Wells Fargo upgraded to Peer Perform from Underperform at Wolfe Research
07/08/20 JPMorgan
Wells Fargo price target lowered to $29.50 from $32 at JPMorgan
07/08/20 Seaport Global
Wells Fargo initiated with a Neutral at Seaport Global
WFC Wells Fargo
$24.14 /

-1.29 (-5.07%)

WFC Wells Fargo
$24.14 /

-1.29 (-5.07%)

WFC Wells Fargo
$24.14 /

-1.29 (-5.07%)

WFC Wells Fargo
$24.14 /

-1.29 (-5.07%)

Conference/Events
Herman Miller management to meet virtually with Sidoti » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
MLHR

Herman Miller

$21.37 /

+0.23 (+1.09%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MLHR Herman Miller
$21.37 /

+0.23 (+1.09%)

MLHR Herman Miller
$21.37 /

+0.23 (+1.09%)

06/30/20 Sidoti
Herman Miller upgraded to Buy from Neutral at Sidoti
05/22/20 Benchmark
Herman Miller initiated with a Buy at Benchmark
03/19/20 Sidoti
Herman Miller downgraded to Neutral from Buy at Sidoti
02/03/20 Sidoti
Herman Miller upgraded to Buy on expected order bounceback at Sidoti
MLHR Herman Miller
$21.37 /

+0.23 (+1.09%)

MLHR Herman Miller
$21.37 /

+0.23 (+1.09%)

MLHR Herman Miller
$21.37 /

+0.23 (+1.09%)

Hot Stocks
DB Gold Double Long falls -9.1% » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
DGP

DB Gold Double Long

$50.80 /

-3.7 (-6.79%)

DB Gold Double Long is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Mesabi Trust falls -10.6% » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
MSB

Mesabi Trust

$15.55 /

-2.075 (-11.77%)

Mesabi Trust is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSB Mesabi Trust
$15.55 /

-2.075 (-11.77%)

MSB Mesabi Trust
$15.55 /

-2.075 (-11.77%)

Hot Stocks
Mogu falls -12.2% » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
MOGU

Mogu

$3.25 /

-0.41 (-11.20%)

Mogu is down -12.2%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOGU Mogu
$3.25 /

-0.41 (-11.20%)

MOGU Mogu
$3.25 /

-0.41 (-11.20%)

03/17/20 China Renaissance
Mogu upgraded to Buy from Hold at China Renaissance
Hot Stocks
Puxin Limited rises 12.0% » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
NEW

Puxin Limited

$9.00 /

+1 (+12.50%)

Puxin Limited is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEW Puxin Limited
$9.00 /

+1 (+12.50%)

NEW Puxin Limited
$9.00 /

+1 (+12.50%)

11/18/19 Citi
Puxin Limited upgraded to Buy from Neutral at Citi
Recommendations
M&G Plc price target lowered to 172 GBp from 188 GBp at Morgan Stanley » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
MGPUF

M&G Plc

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGPUF M&G Plc
$0.00 /

+ (+0.00%)

07/02/20 JPMorgan
M&G Plc price target lowered to 227 GBp from 235 GBp at JPMorgan
05/28/20 Deutsche Bank
M&G Plc price target raised to 210 GBp from 200 GBp at Deutsche Bank
04/23/20 Deutsche Bank
M&G Plc price target lowered to 200 GBp from 295 GBp at Deutsche Bank
04/01/20 RBC Capital
M&G Plc upgraded to Outperform from Sector Perform at RBC Capital
Hot Stocks
Garrett Motion rises 14.8% » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
GTX

Garrett Motion

$6.00 /

+0.75 (+14.29%)

Garrett Motion is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTX Garrett Motion
$6.00 /

+0.75 (+14.29%)

GTX Garrett Motion
$6.00 /

+0.75 (+14.29%)

09/13/19 BofA/Merrill
Garrett Motion upgraded to Neutral from Underperform at BofA/Merrill
09/10/19 Morgan Stanley
Garrett Motion initiated with an Underweight at Morgan Stanley
09/05/19 Barclays
LBOs could provide floor in auto parts valuations, says Barclays
GTX Garrett Motion
$6.00 /

+0.75 (+14.29%)

GTX Garrett Motion
$6.00 /

+0.75 (+14.29%)

Hot Stocks
Lumber Liquidators rises 16.0% » 12:00
07/14/20
07/14
12:00
07/14/20
12:00
LL

Lumber Liquidators

$15.89 /

+2.18 (+15.90%)

Lumber Liquidators is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LL Lumber Liquidators
$15.89 /

+2.18 (+15.90%)

LL Lumber Liquidators
$15.89 /

+2.18 (+15.90%)

07:28 Today Loop Capital
Lumber Liquidators upgraded to Buy from Hold at Loop Capital
05/29/20 Stifel
Lumber Liquidators price target raised to $10 from $5 at Stifel
01/21/20
Fly Intel: Top five analyst downgrades
01/21/20 Morgan Stanley
Lumber Liquidators downgraded to Underweight from Equal Weight at Morgan Stanley
LL Lumber Liquidators
$15.89 /

+2.18 (+15.90%)

LL Lumber Liquidators
$15.89 /

+2.18 (+15.90%)

LL Lumber Liquidators
$15.89 /

+2.18 (+15.90%)

Syndicate
nCino opens at $71, IPO priced $31 per share  11:59
07/14/20
07/14
11:59
07/14/20
11:59
NCNO

nCino

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 14
    Jul
NCNO nCino
$0.00 /

+ (+0.00%)

Conference/Events
BNY Mellon management to meet virtually with Wolfe Research » 11:58
07/14/20
07/14
11:58
07/14/20
11:58
BK

BNY Mellon

$39.05 /

+0.19 (+0.49%)

Wolfe Research Banks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BK BNY Mellon
$39.05 /

+0.19 (+0.49%)

BK BNY Mellon
$39.05 /

+0.19 (+0.49%)

07/08/20 Seaport Global
BNY Mellon initiated with a Buy at Seaport Global
07/08/20 Jefferies
BNY Mellon upgraded to Buy on positive EPS revisions at Jefferies
07/08/20 Jefferies
BNY Mellon upgraded to Buy from Hold at Jefferies
06/11/20 Deutsche Bank
BNY Mellon named short-term investment idea at Deutsche Bank
BK BNY Mellon
$39.05 /

+0.19 (+0.49%)

BK BNY Mellon
$39.05 /

+0.19 (+0.49%)

BK BNY Mellon
$39.05 /

+0.19 (+0.49%)

BK BNY Mellon
$39.05 /

+0.19 (+0.49%)

Recommendations
Umicore price target raised to EUR 28 from EUR 25 at Morgan Stanley » 11:58
07/14/20
07/14
11:58
07/14/20
11:58
UMICY

Umicore

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UMICY Umicore
$0.00 /

+ (+0.00%)

07/08/20 UBS
Umicore price target raised to EUR 35 from EUR 31 at UBS
07/06/20 Barclays
Umicore price target raised to EUR 34 from EUR 32 at Barclays
06/17/20 JPMorgan
Umicore price target raised to EUR 34.50 from EUR 32.70 at JPMorgan
06/17/20 UBS
Umicore price target raised to EUR 31 from EUR 30 at UBS
UMICY Umicore
$0.00 /

+ (+0.00%)

Recommendations
LVMH price target raised to EUR 470 from EUR 445 at Morgan Stanley » 11:58
07/14/20
07/14
11:58
07/14/20
11:58
LVMUY

LVMH

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVMUY LVMH
$0.00 /

+ (+0.00%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

06/24/20 Morgan Stanley
LVMH price target raised to EUR 445 from EUR 440 at Morgan Stanley
06/05/20 Societe Generale
SocGen backs Buy on LVMH after Tiffany statement
06/05/20 Societe Generale
Societe Generale still sees LVMH going through with deal for Tiffany
06/03/20 RBC Capital
LVMH price target raised to EUR 400 from EUR 390 at RBC Capital
LVMUY LVMH
$0.00 /

+ (+0.00%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

Recommendations
Legal & General price target raised to 273 GBp from 265 GBp at Morgan Stanley » 11:57
07/14/20
07/14
11:57
07/14/20
11:57
LGGNY

Legal & General

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGGNY Legal & General
$0.00 /

+ (+0.00%)

07/13/20 BofA
Legal & General upgraded to Buy from Neutral at BofA
06/23/20 Berenberg
Legal & General initiated with a Hold at Berenberg
06/09/20 BofA
Legal & General downgraded to Neutral from Buy at BofA
04/23/20 Deutsche Bank
Legal & General price target lowered to 295 GBp from 335 GBp at Deutsche Bank
Recommendations
Ipsen price target raised to EUR 90 from EUR 88 at Morgan Stanley » 11:56
07/14/20
07/14
11:56
07/14/20
11:56
IPSEY

Ipsen

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$0.00 /

+ (+0.00%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

06/08/20 Bryan Garnier
Ipsen upgraded to Buy from Neutral at Bryan Garnier
06/01/20 Barclays
Ipsen price target raised to EUR 72 from EUR 62 at Barclays
06/01/20 BofA
Ipsen upgraded to Buy from Neutral at BofA
05/18/20 JPMorgan
Ipsen upgraded to Neutral on Cabometyx potential at JPMorgan
IPSEY Ipsen
$0.00 /

+ (+0.00%)

Conference/Events
Agnico Eagle management to virtually meet with Needham » 11:56
07/14/20
07/14
11:56
07/14/20
11:56
AEM

Agnico Eagle

$64.09 /

+1.76 (+2.82%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEM Agnico Eagle
$64.09 /

+1.76 (+2.82%)

AEM Agnico Eagle
$64.09 /

+1.76 (+2.82%)

05/01/20 TD Securities
Agnico Eagle price target lowered to C$76 from C$77 at TD Securities
05/01/20 BMO Capital
Agnico Eagle price target raised to C$60 from C$54 at BMO Capital
05/01/20 CIBC
CIBC backs Outperformer on Agnico Eagle after 'solid' Q1 results
05/01/20 RBC Capital
Agnico Eagle's Q1 results mixed relative to expectations, says RBC Capital
AEM Agnico Eagle
$64.09 /

+1.76 (+2.82%)

AEM Agnico Eagle
$64.09 /

+1.76 (+2.82%)

AEM Agnico Eagle
$64.09 /

+1.76 (+2.82%)

Conference/Events
Natera participates in a conference call hosted by Cowen » 11:54
07/14/20
07/14
11:54
07/14/20
11:54
NTRA

Natera

$46.37 /

+0.5 (+1.09%)

Cowen Medical Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTRA Natera
$46.37 /

+0.5 (+1.09%)

NTRA Natera
$46.37 /

+0.5 (+1.09%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
06/09/20 Piper Sandler
Natera transferred with an Overweight at Piper Sandler
05/14/20 Piper Sandler
Natera price target raised to $56 from $49 at Piper Sandler
05/07/20 JPMorgan
Natera upgraded to Overweight on 'de-risked' story at JPMorgan
NTRA Natera
$46.37 /

+0.5 (+1.09%)

  • 17
    Oct
Recommendations
Munich Re price target raised to EUR 275 from EUR 235 at Morgan Stanley » 11:54
07/14/20
07/14
11:54
07/14/20
11:54
MURGY

Munich Re

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MURGY Munich Re
$0.00 /

+ (+0.00%)

MURGY Munich Re
$0.00 /

+ (+0.00%)

06/11/20 Barclays
Munich Re price target lowered to EUR 244 from EUR 246 at Barclays
06/08/20 Oddo BHF
Munich Re downgraded to Reduce from Neutral at Oddo BHF
05/27/20 UBS
Munich Re price target lowered to EUR 195 from EUR 255 at UBS
05/05/20 Deutsche Bank
Munich Re price target lowered to EUR 210 from EUR 227 at Deutsche Bank
Recommendations
Hannover Re price target raised to EUR 170 from EUR 148 at Morgan Stanley » 11:52
07/14/20
07/14
11:52
07/14/20
11:52
HVRRY

Hannover Re

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HVRRY Hannover Re
$0.00 /

+ (+0.00%)

06/23/20 Berenberg
Hannover Re initiated with a Hold at Berenberg
06/11/20 Barclays
Hannover Re price target lowered to EUR 120 from EUR 120.30 at Barclays
05/19/20 HSBC
Hannover Re upgraded to Hold from Reduce at HSBC
05/12/20 Nord/LB
Hannover Re downgraded to Hold from Buy at Nord/LB
Recommendations
Blueprint Medicines price target raised to $100 from $90 at Baird » 11:51
07/14/20
07/14
11:51
07/14/20
11:51
BPMC

Blueprint Medicines

$78.47 /

+1.65 (+2.15%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$163.85 /

+1.82 (+1.12%)

Baird analyst Michael Ulz…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$78.47 /

+1.65 (+2.15%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$163.85 /

+1.82 (+1.12%)

BPMC Blueprint Medicines
$78.47 /

+1.65 (+2.15%)

11:46 Today Piper Sandler
Blueprint Medicines' deal with Roche neutral on model, says Piper Sandler
11:38 Today Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
06/12/20 Piper Sandler
Piper Sandler remains on sidelines with Blueprint Medicines following update
06/08/20 Deutsche Bank
Blueprint Medicines price target raised to $85 from $70 at Deutsche Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

11:46 Today Piper Sandler
Blueprint Medicines' deal with Roche neutral on model, says Piper Sandler
11:38 Today Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/13/20 Bernstein
Roche initiated with an Outperform at Bernstein
07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
LLY Eli Lilly
$163.85 /

+1.82 (+1.12%)

11:38 Today Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
06/29/20 Mizuho
Eli Lilly price target raised to $164 from $155 at Mizuho
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
BPMC Blueprint Medicines
$78.47 /

+1.65 (+2.15%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$163.85 /

+1.82 (+1.12%)

  • 23
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$163.85 /

+1.82 (+1.12%)

BPMC Blueprint Medicines
$78.47 /

+1.65 (+2.15%)

RHHBY Roche
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$163.85 /

+1.82 (+1.12%)

LLY Eli Lilly
$163.85 /

+1.82 (+1.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.